Updated:
XGEN Venture
We are here to build next generation life science ventures. Scroll At XGEN we specialize in early stage investments in private research & development...
XGEN Venture
We are here to build next generation life science ventures. Scroll At XGEN we specialize in early stage investments in private research & development companies in the life sciences sector. XGEN Venture is an Italian alternative investment fund manager (Società di Gestione del Risparmio, or SGR) established in 2021 by the former Genextra team, with […]
General information
Firm type
Venture Capital
Year founded
2022
Location
Region
Europe
Country
Italy
City
Milan
Corporate office
Milan, Italy
Principals
Federico de Mojana
Founding Partner
Lorenzo Allevi
Founding Partner
Andrea Pescatori
Founding Partner
Rocco Bova
Founding Partner
Enrico Miraglia
Operating Partner
Sector focus
Frequently asked questions
Does XGEN Venture focus on specific sectors, or is the mandate broad?
XGEN targets biotech, medtech, and deep-tech — a specialist life-science and frontier-technology mandate rather than a generalist venture approach. Within deep-tech, the firm also evaluates enterprise software, AI/ML, and climate-adjacent industrial technology. The team does not publicly advertise consumer-tech investments, and its deal flow is anchored in university and hospital research networks.
How large is XGEN Venture's fund, and who backed the first close?
The debut fund closed at €160 million in 2023. Limited partners include Italian institutional investors, European fund-of-funds, and family offices, though specific names have not been published. The fund size places XGEN among the larger first-time science-focused VC funds raised in Southern Europe that year.
What investment stage does XGEN Venture target?
Pre-seed and seed stages are the core, with reserves allocated for follow-on participation through Series A and occasionally Series B. The firm leads rounds and takes board seats, positioning itself as an institutional first-check investor rather than a passive small-allocator. Check sizes and ownership targets have not been publicly disclosed.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: